Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
4.92%15.151.8%$165.06m
VRXValeant Pharmaceuticals International, Inc.
2.01%21.3014.1%$125.33m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.83%154.196.2%$81.03m
PRGOPerrigo Co. Plc
1.05%46.156.8%$70.07m
SAGESAGE Therapeutics, Inc.
0.60%162.008.6%$61.94m
JAZZJazz Pharmaceuticals Plc
2.62%134.832.3%$54.72m
HZNPHorizon Pharma plc
0.60%27.006.7%$46.88m
UTHRUnited Therapeutics Corporation
2.33%81.3714.3%$44.61m
PTLAPortola Pharmaceuticals, Inc.
-0.36%30.417.5%$42.98m
ICLRICON Plc
1.32%157.174.1%$40.19m
ICPTIntercept Pharmaceuticals, Inc.
-0.99%64.0017.2%$38.64m
CTLTCatalent Inc
1.10%55.882.4%$35.42m
MDCOMedicines Company
3.78%32.7120.3%$33.51m
AERIAerie Pharmaceuticals, Inc.
-5.62%23.196.8%$25.01m
PCRXPacira Pharmaceuticals, Inc.
-1.85%38.2210.5%$24.00m

Company Profile

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.